DR. PREDIMAN SHAH, MD
Osteopathic Medicine at Beverly Blvd, Los Angeles, CA
License number
California A31604
Category
Osteopathic Medicine
Type
Cardiovascular Disease
License number
California A31604
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
8700 Beverly Blvd, Los Angeles, CA 90048
Phone
(310) 423-3844
(310) 423-0144 (Fax)
(310) 423-3884
(310) 423-0144 (Fax)
(310) 423-3884
Personal information
See more information about PREDIMAN SHAH at radaris.comName
Address
Phone
111 N Layton Dr, Los Angeles, CA 90049
111 N Layton Dr, Los Angeles, CA 90049
2040 Roscomare Rd, Los Angeles, CA 90077
432 Curson Ave E #4F, Los Angeles, CA 90036
4748 La Villa Marina H, Venice, CA 90292
Organization information
See more information about PREDIMAN SHAH at bizstanding.comPrediman Shah MD,MBBS,BS
8700 Beverly Blvd, Los Angeles, CA 90048
Industry:
Cardiologist, Internist
Phone:
(310) 423-3884 (Phone)
Prediman Krishan Shah
Professional information
See more information about PREDIMAN SHAH at trustoria.com
Peptide-Based Immunization Therapy For Treatment Of Atherosclerosis And Development Of Peptide-Based Assay For Determination Of Immune Responses Against Oxidized Low Density Lipoprotein
Peptide-Based Immunization Therapy For Treatment Of Atherosclerosis And Development Of Peptide-Based Assay For Determination Of Immune Responses Against Oxidized Low Density Lipoprotein
US Patent:
2003010, Jun 5, 2003
Filed:
Apr 4, 2002
Appl. No.:
10/115072
Inventors:
Jan Nilsson - Genarp, SE
Prediman Shah - Los Angeles CA, US
Prediman Shah - Los Angeles CA, US
International Classification:
A61K038/17, C07K014/775
US Classification:
514/012000, 530/359000
Abstract:
The present invention relates to fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing ischemic cardiovascular diseases, using one or more of said peptides in an ELISA (Enzyme Linked Immuno Sorbent Assay).
Methods For Treating Vascular Disease By Inhibiting Toll-Like Receptor-4
Methods For Treating Vascular Disease By Inhibiting Toll-Like Receptor-4
US Patent:
2003007, Apr 24, 2003
Filed:
Apr 23, 2002
Appl. No.:
10/128166
Inventors:
Moshe Arditi - Encino CA, US
Tripathi Rajavashisth - El Camino Village CA, US
Prediman Shah - Los Angeles CA, US
Tripathi Rajavashisth - El Camino Village CA, US
Prediman Shah - Los Angeles CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER
International Classification:
A61K048/00, A61K039/395, A61M031/00
US Classification:
424/144100, 514/044000, 604/500000
Abstract:
Methods included herein describe the treatment of atherosclerosis and other vascular diseases such as thrombosis, restenosis after angioplasty and/or stenting, and vein-graft disease after bypass surgery, by inhibition of the expression or biologic activity of Toll-like receptor-4 (TLR-4). Also included is an intravascular device coated with a compound that inhibits TLR-4; thereby imparting an improved efficacy to the device. TLR-4 cell signal transduction is at least partially responsible for the manifestation, continuation, and/or worsening of atherosclerosis and other forms of vascular disease. The present invention provides several means with which to inhibit this signal transduction pathway.
Peptide Epitopes Of Apolipoprotein B
Peptide Epitopes Of Apolipoprotein B
US Patent:
2010018, Jul 22, 2010
Filed:
Dec 22, 2009
Appl. No.:
12/644810
Inventors:
Jan Nilsson - Genarp, SE
Prediman K. Shah - Los Angeles CA, US
Prediman K. Shah - Los Angeles CA, US
Assignee:
FORSKARPATENT I SYD - LUND
CEDARS SINAI MEDICAL CENTER - Los Angeles CA
CEDARS SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
A61K 39/00, C07K 14/775, A61K 9/127, A61K 38/17, A61K 38/38, A61P 9/10
US Classification:
424450, 530326, 514 13, 514 12, 4241851
Abstract:
The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of said antibodies.
Peptide Epitopes Of Apolipoprotein B
Peptide Epitopes Of Apolipoprotein B
US Patent:
7528225, May 5, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/930625
Inventors:
Jan Nilsson - Genarp, SE
Prediman K. Shah - Los Angeles CA, US
Prediman K. Shah - Los Angeles CA, US
Assignee:
Forskarpapatent I Syd - Lund
Cedars Sinai Medical Center - Los Angeles CA
Cedars Sinai Medical Center - Los Angeles CA
International Classification:
C07K 4/12, A61K 38/04
US Classification:
530326, 530300, 514 13, 4241851
Abstract:
The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of said antibodies.
Antibodies Against A Peptide Epitope Of Apoliprotein B
Antibodies Against A Peptide Epitope Of Apoliprotein B
US Patent:
8034336, Oct 11, 2011
Filed:
Feb 27, 2009
Appl. No.:
12/394919
Inventors:
Jan Nilsson - Genarp, SE
Prediman K. Shah - Los Angeles CA, US
Prediman K. Shah - Los Angeles CA, US
Assignee:
Forskarpaten I SYD - Lund
Cedars-Sinai Medical Center - Los Angeles CA
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
C07K 4/12, C07K 16/18, A61K 39/395
US Classification:
4241301, 4241391, 514 214, 530326, 5303871, 5303879
Abstract:
The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of the antibodies.
Lipoprotein Lipase And Its Effect On Statin Treatments
Lipoprotein Lipase And Its Effect On Statin Treatments
US Patent:
2010013, May 27, 2010
Filed:
Mar 28, 2008
Appl. No.:
12/594143
Inventors:
Mark O. Goodarzi - Los Angeles CA, US
Kent D. Taylor - Ventura CA, US
Maren T. Scheuner - Manhattan Beach CA, US
Xiuqing Guo - Santa Monica CA, US
Prediman K. Shah - Los Angeles CA, US
Jerome I. Rotter - Los Angeles CA, US
Kent D. Taylor - Ventura CA, US
Maren T. Scheuner - Manhattan Beach CA, US
Xiuqing Guo - Santa Monica CA, US
Prediman K. Shah - Los Angeles CA, US
Jerome I. Rotter - Los Angeles CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
C12Q 1/68, A61K 31/366
US Classification:
514460, 435 6
Abstract:
The invention provides methods of treating and prognosing atherosclerosis and lipid response to statin treatment by determining the presence or absence of haplotypes at the lipoprotein lipase locus. In one embodiment, the invention is practiced by evaluating the prognosis of vascular grafts in an individual undergoing statin treatment by determining the presence or absence of haplotypes at the lipoprotein locus.
Inhibition Of Smooth Muscle Cell Migration By Tenascin-C Peptides
Inhibition Of Smooth Muscle Cell Migration By Tenascin-C Peptides
US Patent:
6124260, Sep 26, 2000
Filed:
Sep 30, 1998
Appl. No.:
9/164021
Inventors:
Behrooz G. Sharifi - Woodland Hills CA
Prediman K. Shah - Los Angeles CA
Prediman K. Shah - Los Angeles CA
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
A61K 3800
US Classification:
514 12
Abstract:
Peptides capable of interacting with smooth muscle cells are provided. Peptides are derived from Tenascin-C protein, particularly from the Fbg-L domain of Tenascin-C protein. Peptides of the present invention are useful in inhibiting smooth muscle cell migration. Methods of inhibiting smooth muscle cell adhesion and migration are also provided. Methods of the present invention may be used for treating intimal hyperplasia, restenosis, and atherosclerosis.
Antibodies Against A Peptide Epitope Of Apolipoprotein B
Antibodies Against A Peptide Epitope Of Apolipoprotein B
US Patent:
7537758, May 26, 2009
Filed:
Jul 12, 2006
Appl. No.:
11/485549
Inventors:
Jan Nilsson - Genarp, SE
Prediman K. Shah - Los Angeles CA, US
Prediman K. Shah - Los Angeles CA, US
Assignee:
Forskarpatent I SYD AB - Lund
Cedars Sinai Medical Center - Los Angeles CA
Cedars Sinai Medical Center - Los Angeles CA
International Classification:
A61K 39/395, C07K 16/18, C07K 4/12
US Classification:
4241301, 530326, 5303871, 5303879, 4241391
Abstract:
The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of said antibodies.
Antibodies Against A Peptide Epitope Of Apolipoprotein B
Antibodies Against A Peptide Epitope Of Apolipoprotein B
US Patent:
8029786, Oct 4, 2011
Filed:
Feb 27, 2009
Appl. No.:
12/394886
Inventors:
Jan Nilsson - Genarp, SE
Prediman K. Shah - Los Angeles CA, US
Prediman K. Shah - Los Angeles CA, US
Assignee:
Forskarpatent I SYD - Lund
Cedars Sinai Medical Center - Los Angeles CA
Cedars Sinai Medical Center - Los Angeles CA
International Classification:
C07K 4/12, C07K 16/18, A61K 39/395
US Classification:
4241301, 4241391, 514 214, 530326, 5303871, 5303879
Abstract:
The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of the antibodies.
Peptide-Based Immunization Therapy For Treatment Of Atherosclerosis
Peptide-Based Immunization Therapy For Treatment Of Atherosclerosis
US Patent:
2009022, Sep 10, 2009
Filed:
Feb 27, 2009
Appl. No.:
12/394744
Inventors:
Jan Nilsson - Genarp, SE
Prediman K. Shah - Los Angeles CA, US
Prediman K. Shah - Los Angeles CA, US
Assignee:
FORSKARPATENT I SYD - Lund
CEDARS SINAI MEDICAL CENTER - Los Angeles CA
CEDARS SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
A61K 39/00, C07K 14/00, A61K 38/16, G01N 33/566, G01N 33/53
US Classification:
4241851, 530326, 514 13, 436501, 435 792
Abstract:
The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of said antibodies.